|
GART expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.29120000000616E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.639600E-04 |
| Normal-vs-Stage2 |
8.641600E-04 |
| Normal-vs-Stage3 |
1.80502000000082E-05 |
| Normal-vs-Stage4 |
2.38169999999815E-06 |
| Stage1-vs-Stage2 |
3.910400E-01 |
| Stage1-vs-Stage3 |
8.809900E-02 |
| Stage1-vs-Stage4 |
4.954200E-02 |
| Stage2-vs-Stage3 |
7.170000E-01 |
| Stage2-vs-Stage4 |
3.854600E-01 |
| Stage3-vs-Stage4 |
5.287400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.989790E-04 |
| Normal-vs-AfricanAmerican |
7.519600E-03 |
| Normal-vs-Asian |
6.283900E-03 |
| Caucasian-vs-AfricanAmerican |
9.194400E-01 |
| Caucasian-vs-Asian |
8.585200E-01 |
| AfricanAmerican-vs-Asian |
8.375800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.83299999995312E-06 |
| Normal-vs-Female |
2.352900E-04 |
| Male-vs-Female |
7.133600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.801200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.18719999999228E-05 |
| Normal-vs-Age(61-80Yrs) |
1.85085999999668E-05 |
| Normal-vs-Age(81-100Yrs) |
1.172220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.278590E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.907900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.753400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.356400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.329400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.867600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.932160E-01 |
| Classical-VS-Follicular |
4.02269999999483E-06 |
| Classical-VS-Other |
5.528300E-02 |
| Classical-VS-Normal |
3.179200E-03 |
| Tall-VS-Follicular |
1.584590E-01 |
| Tall-VS-Other |
2.443000E-01 |
| Tall-VS-Normal |
1.639550E-03 |
| Follicular-VS-Other |
7.285200E-01 |
| Follicular-VS-Normal |
7.43400000446925E-08 |
| Other-VS-Normal |
2.257900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.00659999999298E-05 |
| Normal-vs-N1 |
1.58177999999287E-05 |
| N0-vs-N1 |
2.675400E-01 |
|
|
